Multiple Infusions of Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (EMD 55 900) in Patients with Recurrent Malignant Gliomas

European Journal of Cancer

Volumn 32, Issue 4, 1996, Pages 636-640

  Stragliotto, G ^a,c   Vega, F ^a   Stasiecki, P ^b   Gropp, P ^b   Poisson, M ^a   Delattre, J Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MERCK KGAA   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Epidermal growth factor urogastrone; Glioma; Immunotherapy; Murine monoclonal antibody; Receptors

Indexed keywords

CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EMD 55 900; PROCARBAZINE; THIOTEPA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; ERYTHEMA; FEMALE; GLIOMA; HEPATITIS; HUMAN; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS;

EID: 0029931490     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00592-7     Document Type: Article

References (21)

1. Liberman TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H. Expression of EGF receptors in human brain tumors. Cancer Res 1984, 44, 753-760.
2. Humphrey PA, Wong AJ, Vogelstein B et al. Anti-synthetic peptide antibody reaching at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 1990, 87, 4207-4211.
3. Strommer K, Hamou MF, Diggelmann H, de Tribolet N. Cellular and tumoral heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir (Wien) 1990, 107, 82-87.
4. Von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993, 3, 19-26.
5. Dajmanov I, Mildner B, Knowles BB. Immunohistochemical localization of the Epidermal Growth Factor Receptor in normal human tissues. Lab Invest 1986, 55, 588-592.
6. Faillot T, Magdelenat H, Mady E, Fohanno D, Poisson M, Delattre JY. A phase I study of an anti-EGF receptor monoclonal antibody for the treatment of malignant gliomas. Neurology 1991, 41, 833 (abstract).
7. Bilzer T, Stasiecki P, Schober R, et al. Multiple injections of Monoclonal antibody EMD 55 900: evidence of MAb-mediated immune cell reactions. Abstract, May 1993, 48th Annual Meeting of the American Association for Cancer Research, Orlando, U.S.A., May 1993.
8. Murthy U, Basu A, Rodeck U, Herlyn M, Ross AH, Das M. Binding of an antagonistic monoclonal antibody to an intact and fragmented EGFR-receptor polypeptide. Arch Biochem Biophys 1987, 252, 549-560.
9. MacDonald DR, Cascino TL, Schold SC, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990, 8, 1277-1280.
10. Behnke J, Coakham HB, Mach JP, Carrel S, de Tribolet N. Monoclonal antibodies in the diagnosis and therapy of brain tumors. In Komblith PL, Walker MD (eds). Advances in Neurooncology, Mount Kisco, NY, Futura, 1988, 249-285.
11. Collins VP. Amplified genes in human gliomas. Semin Cancer Biol 1993, 4, 27-33.
12. Wilkstrand CJ, Fredman P, Svennerhilm L, Humphrey PA, Bigner SH, Bigner DD. Monoclonal antibodies to malignant human gliomas. Mol Chem Neuropathol 1992, 17, 137-146.
13. Bender H, Takahashi H, Adachi K, et al. Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor. Cancer Res 1992, 52, 121-126.
14. Steck PA, Gallick GE, Maxwell SA et al. Expression of EGF receptor and associated glycoprotein on cultured human brain tumor cells. J Cell Biochem 1986, 32, 1-10.
15. Takahashi H, Herlyn D, Atkinson B, et al. Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res 1987, 47, 3847-3850.
16. Dillmann RO. Antibodies as cytotoxic therapy. J Clin Oncol 1994, 12, 1497-1515.
17. Cheung NK, Lazarus H, Miraldi FD, et al. Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 1987, 5, 1430-1440.
18. Murray JL, Cunningham JE, Brewer H et al. Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J Clin Oncol 1994, 12, 184-193.
19. Roszman T, Elliott L, Brooks W. Modulation of T-cell function by gliomas. Immunol Today 1991, 12, 370-374.
20. Kuppner MC, Hamou MF, Sawamura Y, Bodmer S, de Tribolet N. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2. J Neurosurg 1989, 71, 211-217.
21. Baselga J, Norton L, Masui H, et al. Antitumour effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 1993, 85, 1327-1333.